(Q50969719)

English

Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.

scientific article published in July 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/17594200

Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/17594200

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

author name string

David Cobden

1

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/17594200

Won Chan Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/17594200

Sanjeev Balu

3

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/17594200

Ashish V Joshi

4

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/17594200

Chris L Pashos

5

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/17594200

language of work or name

0 references

publication date

1 July 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/17594200

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/17594200

27

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/17594200

7

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/17594200

948-962

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/17594200

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Potential short-term economic benefits of improved glycemic control: a managed care perspective

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Effect of improved glycemic control on health care costs and utilization

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Cost of hypoglycemia in patients with Type 2 diabetes in Sweden

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Standards of medical care in diabetes

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Management of type 2 diabetes in the primary care setting: a practice-based research network study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Factors that influence improvement for patients with poorly controlled type 2 diabetes

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Before oral agents fail: the case for starting insulin early

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

FlexPen: addressing issues of confidence and convenience in insulin delivery

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Assessment of dose selection attributes with audible notification in insulin pen devices.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Economic costs of diabetes in the US in 2002.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mell

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Preference for insulin delivery systems among current insulin users and nonusers.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Frequency and perceived burden of diabetes self-management activities in employees with insulin-treated diabetes: relationships with health outcomes.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Development and validation of the insulin treatment satisfaction questionnaire.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Biphasic insulin aspart vs. human insulin in adolescents with type 1 diabetes on multiple daily insulin injections

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin products

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Conversion to atorvastatin in patients intolerant or refractory to simvastatin therapy: the CAPISH study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) program

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

The effects of improved glycemic control on complications in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Long-term complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Patient adherence improves glycemic control

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

The association between diabetes metabolic control and drug adherence in an indigent population

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Hypoglycemia in diabetes.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Pharmacy benefits and the use of drugs by the chronically ill.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.7.948

21 January 2018

Identifiers

10.1592/PHCO.27.7.948

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/17594200

release_27v27kb6svdbbgc6pjsh3zkrqu

1 reference

https://api.fatcat.wiki/v0/release/27v27kb6svdbbgc6pjsh3zkrqu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/17594200

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50969719&oldid=1836064315"